Certified by Founder Lodge
Amgen
United States - Thousand Oaks, CA
INVESTOR
1 Disclosed Funding Rounds $112,000,000
9 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics.
Company | Date | Round | Raised |
---|---|---|---|
Neumora | October, 17 ,2022 | Series B | $112,000,000 |
ImmunoScape | September, 26 ,2022 | Unknown | $14,000,000 |
CancerIQ | March, 04 ,2022 | Series B | $14,000,000 |
Feldan Therapeutics | June, 14 ,2023 | Series B | $16,500,000 |
Generate:Biomedicines | September, 18 ,2023 | Series C | $273,000,000 |
ReCode Therapeutics | September, 20 ,2023 | Series B | $50,000,000 |
Culmination Bio | December, 01 ,2023 | Unknown | $10,000,000 |
Seismic Therapeutic | December, 05 ,2023 | Series B | $121,000,000 |
Quantinuum | January, 17 ,2024 | Unknown | $300,000,000 |